General / Press Release
Change in SEQENS’ shareholding structure
SEQENS is now stronger, more focused and positioned as one of the world’s leading players in pharmaceutical solutions and specialty ingredients 3 new…
Read moreNewsroom
General
SEQENS Turku Plant (Finland) reaches 100% Renewable Energy and zero direct carbon emissions
This achievement reflects SEQENS strong commitment to reduce its environmental and carbon footprint in line with the Group ESG Program. SEQENS, an integrated…
Read more
Events
DCAT 2022: a success for Seqens group
From March 21 to 24, 2022, a delegation representing all of the group’s pharmaceutical activities took part in the DCAT event in New York.
Read more
Press Release
SEQENS Makes Multi-Million-Dollar Investment in U.S. R&D Laboratory
Investment Signals Major Commitment to U.S. Market and Builds on Merger with Contract Development and Manufacturing Organization Wavelength Pharmaceuticals. investment in Devens SEQENS,…
Read more
General
Meeting with Virginie Tarlet for the International Women’s Day
For the International Women’s day, SEQENS highlights the career path of inspiring women working within the group. Meet Virginie Tarlet Roussillon Lab manager. What is…
Read more
General
Meeting with Aïna Queiroz for the International Women’s Day
For the International Women’s day, SEQENS highlights the career path of inspiring women working within the group. Meet Aïna Queiroz, Head of innovation and scientific…
Read more
General
Meeting with Yael Gofni for the International Women’s Day
For the International Women’s day, SEQENS highlights the career path of inspiring women working within the group. Meet Yael Gofni analytical…
Read more
General
Update on isopropanol plant expansion
Seqens Solvents & Phenol Specialties (SPS) is proud to confirm that its isopropanol (IPA) plant capacity expansion, originally announced in Q2 2020 and…
Read more
General / Press Release
Change in SEQENS’ shareholding structure
SEQENS is now stronger, more focused and positioned as one of the world’s leading players in pharmaceutical solutions and specialty ingredients 3 new…
Read more
General / Press Release
SK Capital becomes the new majority shareholder of Seqens – Q&A
As announced on the 26th of August 2021, Eurazeo has finalized on Decembre 16th the sale of its stake in SEQENS to funds advised…
Read more
General
Seqens becomes a partner of the RoLA-FLEX project
RoLA-FLEX is an industry-focused project that provides innovative solutions to the challenge associated with th performance and lifetime of Organic…
Read more